Przedstawiamy wybór publikacji naukowych związanych z immunoterapią IOZK. Możesz użyć filtrów, aby dokonać wyboru według typów nowotworów i metod lub wprowadzić wyszukiwane hasła.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002012-05-05 / Case Rep Oncol 2012 May;5(2):212-5https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2012-05-05 / Case Rep Oncol 2012 May;5(2):212-52012-05-05 00:00:002019-02-15 08:48:33Successful treatment of advanced ovarian cancer with thermochemotherapy and adjuvant immune therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002012-05-01 / J. Cell. Biochem. 2012 May;113(5):1547-58https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2012-05-01 / J. Cell. Biochem. 2012 May;113(5):1547-582012-05-01 00:00:002019-02-15 08:39:18Hyperthermia-enhanced TRAIL- and mapatumumab-induced apoptotic death is mediated through mitochondria in human colon cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002012-05-01 / Curr Opin Urol 2012 May;22(3):197-202https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2012-05-01 / Curr Opin Urol 2012 May;22(3):197-2022012-05-01 00:00:002019-02-15 09:23:55Current status of immunological approaches for the treatment of prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002012-04-26 / Braz. J. Med. Biol. Res. 2012 Jun;45(6):510-5https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2012-04-26 / Braz. J. Med. Biol. Res. 2012 Jun;45(6):510-52012-04-26 00:00:002019-02-15 08:50:04Co-culture of apoptotic breast cancer cells with immature dendritic cells: a novel approach for DC-based vaccination in breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002012-04-22 / Cancer Immunol. Immunother. 2012 Nov;61(11):2033-44https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2012-04-22 / Cancer Immunol. Immunother. 2012 Nov;61(11):2033-442012-04-22 00:00:002021-11-15 14:43:58Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002012-04-05 / Cancer Immunol. Immunother. 2012 Nov;61(11):1929-39https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2012-04-05 / Cancer Immunol. Immunother. 2012 Nov;61(11):1929-392012-04-05 00:00:002019-02-15 08:52:15Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002012-04-02 / PLoS ONE 2012;7(4):e32614https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2012-04-02 / PLoS ONE 2012;7(4):e326142012-04-02 00:00:002019-02-15 08:46:34Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002012-03-23 / Lung Cancer 2012 Jul;77(1):140-5https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2012-03-23 / Lung Cancer 2012 Jul;77(1):140-52012-03-23 00:00:002019-07-16 13:13:18Re-irradiation plus regional hyperthermia for recurrent non-small cell lung cancer: a potential modality for inducing long-term survival in selected patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002012-03-22 / Nat. Rev. Cancer 2012 Mar;12(4):252-64https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2012-03-22 / Nat. Rev. Cancer 2012 Mar;12(4):252-642012-03-22 00:00:002019-02-15 08:35:56The blockade of immune checkpoints in cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002012-03-20 / Cancer Immunol. Immunother. 2012 Oct;61(10):1791-804https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2012-03-20 / Cancer Immunol. Immunother. 2012 Oct;61(10):1791-8042012-03-20 00:00:002019-02-15 08:48:48Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial
[Dendritic cell-based therapeutic vaccination for acute myeloid leukemia]
Allogeneic partially HLA-matched dendritic cells (DC) as a vaccine in metastatic renal cell cancer (mRCC): Final analysis of a clinical phase I/II study.
Cancer therapy and vaccination
Cancer immunotherapy: a paradigm shift for prostate cancer treatment
Velogenic newcastle disease virus as an oncolytic virotherapeutics: in vitro characterization
Successful treatment of advanced ovarian cancer with thermochemotherapy and adjuvant immune therapy
Hyperthermia-enhanced TRAIL- and mapatumumab-induced apoptotic death is mediated through mitochondria in human colon cancer cells
Current status of immunological approaches for the treatment of prostate cancer
Co-culture of apoptotic breast cancer cells with immature dendritic cells: a novel approach for DC-based vaccination in breast cancer
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors
Hyperthermia induces cytoskeletal alterations and mitotic catastrophe in p53-deficient H1299 lung cancer cells
Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease
Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients
Cellular immunotherapy using dendritic cells against multiple myeloma
Ponowne napromienianie i regionalna hipertermia w leczeniu nawrotowego niedrobnokomórkowego raka płuca: potencjalna metoda zwiększania długoterminowego przeżycia u wybranych pacjentów
The blockade of immune checkpoints in cancer immunotherapy
Cancer immunotherapy via dendritic cells
Extracellular vesicles–vehicles that spread cancer genes
Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial